High Resolution Immersion Ultrasound for iIOL Power Calculation
To Assess if Using a High Resolution Immersion Ultrasound Measurement Improves Intraocular Lens Power Calculation
1 other identifier
interventional
40
1 country
1
Brief Summary
Assess is the additional use of high resolution immersion ultrasound measurements improve the refractive outcome after cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 19, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedNovember 21, 2018
November 1, 2018
2 years
November 19, 2018
November 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in mean absolute error in refractive outcome
The difference in refractive error will be measured using auto- and subjective refraction
12 months
Secondary Outcomes (2)
Anterior chamber depth and lens thickness measurement
12 months
IOL tilt and decentration
12 months
Study Arms (1)
ArcScan
EXPERIMENTALHigh resolution immersion ultrasound measurement before Cataract surgery
Interventions
Eligibility Criteria
You may qualify if:
- Cataract
- Age 21 and older
- Able to understand the patient information
- Willing to follow the instructions and attend all follow-up visits
- Willing to sign informed consent prior to surgery
You may not qualify if:
- Relevant other ophthalmic diseases that are likely to reduce the refractive outcome, such as pseudoexfoliation syndrome, traumatic cataract, severe corneal scars
- Previous ocular surgeries on the study eye
- Patients who are not able to cooperate, with eccentric fixation or insufficient ability to fixate (tremor, nystagmus)
- Pregnant or lactating women (pregnancy testing will be performed preoperatively on women of reproductive age)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, 1140, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 19, 2018
First Posted
November 21, 2018
Study Start
January 1, 2018
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
November 21, 2018
Record last verified: 2018-11